✦ LIBER ✦

Discovery and Initial SAR of 3-(1H-Benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as Inhibitors of Insulin-Like Growth Factor 1-Receptor (IGF-1R).

✍ Scribed by Upender Velaparthi; et al. et al.

Publisher: John Wiley and Sons
Year: 2007
Weight: 22 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200735138

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

ChemInform Abstract: Substituted 4-Amino

ChemInform Abstract: Substituted 4-Amino-1H-pyrazolo[3,4-d]pyrimidines as Multi-targeted Inhibitors of Insulin-Like Growth Factor-1 Receptor (IGF1R) and Members of ErbB-Family Receptor Kinases.

✍ Gary T. Wang; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

Potent Platelet-Derived Growth Factor-β

Potent Platelet-Derived Growth Factor-β Receptor (PDGF-βR) Inhibitors: Synthesis and Structure—Activity Relationships of 7-[3-(Cyclohexylmethyl)ureido]-3-{1-methyl-1H-pyrrolo [2,3-b]pyridin-3-yl}quinoxalin-2(1H)-one Derivatives.

✍ Katsuyuki Aoki; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

ChemInform Abstract: Discovery of a Fact

ChemInform Abstract: Discovery of a Factor Xa Inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic Acid 3-[(5-Chloro-pyridin-2-yl)-amide] 4-{[2-Fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a Clinical Candidate.

✍ Wolfgang Haap; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB 👁 2 views

## Abstract Compound (I) is found to be a potent, selective and orally bioavailable fXa inhibitor based on a pyrrolidine scaffold.

ChemInform Abstract: Discovery of N-[2-[

ChemInform Abstract: Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6- [3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl] -N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa.

✍ M. M. MORRISSEY; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views